// App-Quantinova.ai

TCT-1 : Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: One-Year Results From the Disrupt CAD III Study

Researchers

Presenter

  • Jonathan Hill

Principal Investigators

  • Dean Kereiakes

  • Gregg Stone

Medical Centers

  • The Christ Hospital Heart and Vascular Center, Cincinnati, Ohio, USA

  • Cardiovascular Research Foundation, New York, New York, USA

  • The Royal Brompton Hospital, London, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Complex calcified coronary artery lesions

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Single Arm

  • Prospective

Phase

  • NA

Study Id's

  • NCT03595176

Sponsors

  • N/A

Result

  • Final